Citizens JMP Downgrades Vigil Neuroscience Inc (VIGL) to Market Perform

Citizens JMP analyst Jason Butler downgraded Vigil Neuroscience Inc (NASDAQ: VIGL) from Market Outperform to Market Perform.

The analyst comments: "Vigil to be acquired by Sanofi (SNY, NC), securing optimal development investment in VG-3927; we downgrade our rating on Vigil Neuroscience from Market Outperform to Market Perform, and we view it as highly likely that the transaction will close as announced. This evening, Vigil announced that it is to be acquired by Sanofi for $8/share (~$470MM EV) with a $2/share CVR. We view Sanofi as a clearly logical acquirer given its right to first negotiation for VG-3927."

For an analyst ratings summary and ratings history on Vigil Neuroscience Inc click here. For more ratings news on Vigil Neuroscience Inc click here.

Shares of Vigil Neuroscience Inc closed at $2.31 yesterday.

You May Also Be Interested In

• Stripe, Advent In Talks To Buy Paypal - WSJ
• Cantor Fitzgerald Reiterates Overweight Rating on Applied Materials (AMAT)
• Jefferies on Five Below (FIVE): 'Our latest channel checks reinforce our view that FIVE's momentum extends well beyond viral Squish trends'